In-stent neoatherosclerosis: a new problem or an opportunity to rethink the treatment of coronary disease?
作者信息
Ussia Gian Paolo, Cocco Nino
机构信息
Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, Rome, Italy.
Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy.
出版信息
AsiaIntervention. 2024 Sep 27;10(3):153-154. doi: 10.4244/AIJ-E-24-00006. eCollection 2024 Sep.
Abstract
摘要
相似文献
1
In-stent neoatherosclerosis: a new problem or an opportunity to rethink the treatment of coronary disease?支架内新生动脉粥样硬化：一个新问题还是重新思考冠心病治疗的契机？
AsiaIntervention. 2024 Sep 27;10(3):153-154. doi: 10.4244/AIJ-E-24-00006. eCollection 2024 Sep.
2
The negative affectivity dimension of Type D personality is associated with in-stent neoatherosclerosis in coronary patients with percutaneous coronary intervention: An optical coherence tomography study.D 型人格的负性情感维度与经皮冠状动脉介入治疗的冠状动脉患者的支架内新动脉粥样硬化有关：一项光学相干断层扫描研究。
J Psychosom Res. 2019 May;120:20-28. doi: 10.1016/j.jpsychores.2019.03.007. Epub 2019 Mar 6.
3
Neoatherosclerosis in Patients With Coronary Stent Thrombosis: Findings From Optical Coherence Tomography Imaging (A Report of the PRESTIGE Consortium).冠状动脉支架血栓形成患者的新生动脉粥样硬化：光学相干断层成像的研究结果（PRESTIGE 联盟的报告）。
JACC Cardiovasc Interv. 2018 Jul 23;11(14):1340-1350. doi: 10.1016/j.jcin.2018.02.029.
4
Neoatherosclerosis: Coronary stents seal atherosclerotic lesions but result in making a new problem of atherosclerosis.新型动脉粥样硬化：冠状动脉支架可封闭动脉粥样硬化病变，但却引发了一个新的动脉粥样硬化问题。
World J Cardiol. 2015 Nov 26;7(11):776-83. doi: 10.4330/wjc.v7.i11.776.
5
OCT demonstrating neoatherosclerosis as part of the continuous process of coronary artery disease.光学相干断层扫描显示新生动脉粥样硬化是冠状动脉疾病持续过程的一部分。
Herz. 2015 Sep;40(6):845-54. doi: 10.1007/s00059-015-4343-y.
6
Optical coherence tomographic observation of in-stent neoatherosclerosis in lesions with more than 50% neointimal area stenosis after second-generation drug-eluting stent implantation.第二代药物洗脱支架植入术后内膜增生面积狭窄超过50%的病变中支架内新生动脉粥样硬化的光学相干断层扫描观察
Circ Cardiovasc Interv. 2015 Feb;8(2):e001878. doi: 10.1161/CIRCINTERVENTIONS.114.001878.
7
Neoatherosclerosis assessed with optical coherence tomography in restenotic bare metal and first- and second-generation drug-eluting stents.在再狭窄裸金属支架以及第一代和第二代药物洗脱支架中，通过光学相干断层扫描评估的新型动脉粥样硬化。
Int J Cardiovasc Imaging. 2017 Aug;33(8):1115-1124. doi: 10.1007/s10554-017-1106-2. Epub 2017 Mar 9.
8
Neoatherosclerosis: overview of histopathologic findings and implications for intravascular imaging assessment.血管新生动脉硬化：组织病理学发现概述及其对血管内影像学评估的影响。
Eur Heart J. 2015 Aug 21;36(32):2147-59. doi: 10.1093/eurheartj/ehv205. Epub 2015 May 20.
9
A Novel Rabbit Model for In-Stent Neoatherosclerosis.一种用于支架内新生动脉粥样硬化的新型兔模型。
Int Heart J. 2019 Sep 27;60(5):1154-1160. doi: 10.1536/ihj.17-737. Epub 2019 Sep 4.
10
Prevalence and Impact of Neoatherosclerosis on Clinical Outcomes After Percutaneous Treatment of Second-Generation Drug-Eluting Stent Restenosis.第二代药物洗脱支架再狭窄经皮治疗后新生动脉粥样硬化的流行及对临床结局的影响。
Circ Cardiovasc Interv. 2022 Sep;15(9):e011693. doi: 10.1161/CIRCINTERVENTIONS.121.011693. Epub 2022 Sep 20.
本文引用的文献
1
A 2024 scientific update on the clinical performance of drug-coated balloons.2024年药物涂层球囊临床性能的科学更新
AsiaIntervention. 2024 Feb 29;10(1):15-25. doi: 10.4244/AIJ-D-23-00010. eCollection 2024 Feb.
2
Mortality Trends After Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction.ST 段抬高型心肌梗死患者行经皮冠状动脉介入治疗后的死亡率趋势。
J Am Coll Cardiol. 2023 Sep 5;82(10):999-1010. doi: 10.1016/j.jacc.2023.06.025.
3
The Reduction of Mortality in Acute Myocardial Infarction: From Bed Rest to Future Directions.急性心肌梗死死亡率的降低：从卧床休息到未来方向
Int J Prev Med. 2022 Apr 8;13:56. doi: 10.4103/ijpvm.IJPVM_122_20. eCollection 2022.
4
Event Rates and Risk Factors for Recurrent Cardiovascular Events and Mortality in a Contemporary Post Acute Coronary Syndrome Population Representing 239 234 Patients During 2005 to 2018 in the United States.2005 年至 2018 年期间，美国 239234 例急性冠脉综合征患者的心血管事件复发率和死亡率的事件发生率及危险因素分析。
J Am Heart Assoc. 2022 May 3;11(9):e022198. doi: 10.1161/JAHA.121.022198. Epub 2022 Apr 27.
5
Relative contribution of trends in myocardial infarction event rates and case fatality to declines in mortality: an international comparative study of 1·95 million events in 80·4 million people in four countries.趋势在心肌梗死发生率和病死率对死亡率下降的相对贡献：四个国家 8040 万人中 195 万例事件的国际比较研究。
Lancet Public Health. 2022 Mar;7(3):e229-e239. doi: 10.1016/S2468-2667(22)00006-8.
6
Outcomes of Drug-Eluting Stent Thrombosis After Treatment for Acute Versus Chronic Coronary Syndrome.急性与慢性冠状动脉综合征治疗后药物洗脱支架血栓形成的结果。
JACC Cardiovasc Interv. 2021 May 24;14(10):1082-1090. doi: 10.1016/j.jcin.2021.03.051.
7
Targeting the epigenome in in-stent restenosis: from mechanisms to therapy.靶向支架内再狭窄中的表观基因组：从机制到治疗
Mol Ther Nucleic Acids. 2021 Jan 26;23:1136-1160. doi: 10.1016/j.omtn.2021.01.024. eCollection 2021 Mar 5.
8
Stent-Related Adverse Events >1 Year After Percutaneous Coronary Intervention.支架相关不良事件 >1 年经皮冠状动脉介入治疗后。
J Am Coll Cardiol. 2020 Feb 18;75(6):590-604. doi: 10.1016/j.jacc.2019.11.058.
9
Neoatherosclerosis after drug-eluting stent implantation: a novel clinical and therapeutic challenge.药物洗脱支架置入后新生动脉粥样硬化：一种新的临床和治疗挑战。
Eur Heart J Cardiovasc Pharmacother. 2019 Apr 1;5(2):105-116. doi: 10.1093/ehjcvp/pvy036.
10
Neointima and neoatherosclerotic characteristics in bare metal and first- and second-generation drug-eluting stents in patients admitted with cardiovascular events attributed to stent failure: an optical coherence tomography study.心血管事件归因于支架失败而住院的患者中，在裸金属支架和第一代及第二代药物洗脱支架中，新生内膜和新生动脉粥样硬化特征：一项光学相干断层扫描研究。
EuroIntervention. 2018 Feb 2;13(15):e1831-e1840. doi: 10.4244/EIJ-D-17-00051.
Zotero 插件